CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash	$ 20,426	$ 1,004
Prepaid drug product for testing	776	332
Other current assets	788	803
Total current assets	21,990	2,139
Fixed assets
Furniture, fixtures & equipment	1,029	998
Less accumulated depreciation	(726)	(592)
Property, Plant and Equipment, Net	303	406
Right of use operating assets	367	0
Total Assets	22,660	2,545
Current liabilities
Accounts payable	486	587
Accrued expenses	673	740
Current portion of lease liabilities	85	0
Total current liabilities	1,244	1,327
Noncurrent lease liabilities	330	0
Total Liabilities	1,574	1,327
Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value; 200,000 shares authorized; 3,692 and 680 shares issued and outstanding, respectively	4	1
Additional paid in capital	77,421	48,957
Accumulated deficit	(56,339)	(47,740)
Total shareholders' equity	21,086	1,218
Total Liabilities & Shareholders' Equity	$ 22,660	$ 2,545

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).